SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-165186
Filing Date
2013-04-22
Accepted
2013-04-22 17:16:21
Documents
3
Period of Report
2013-05-24
Effectiveness Date
2013-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d511574ddef14a.htm DEF 14A 701117
2 GRAPHIC g511574pc1.jpg GRAPHIC 158403
3 GRAPHIC g511574pc2.jpg GRAPHIC 111312
  Complete submission text file 0001193125-13-165186.txt   1074140
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 13774513
SIC: 2835 In Vitro & In Vivo Diagnostic Substances